NCT07035886View on ClinicalTrials.gov

A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

September 1, 2029

Study Completion Date

March 1, 2031

Conditions
Colorectal Cancer
Interventions
OTHER

No intervention

As this is an observational study, no intervention will be administered.

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY